Since the development of vaccines effective against COVID-19, there has been widespread expert consensus among clinicians in support of vaccination of patients with inflammatory bowel disease on biological therapies or immunomodulators.1 Because these patients were not eligible to participate in the pivotal vaccine development trials, safety and efficacy data were not initially available to guide…
Study identified factors and strategies for maintaining response
Adults newly diagnosed with active Crohn’s disease benefit from immediate treatment with advanced therapies, according to research.
A new study suggests that certain dietary changes may be more effective than medication.
Both a special diet that excludes “FODMAP” compounds and a low-carb high-fibre diet were effective
Two 4-week dietary interventions and optimised medical treatment reduced the severity of IBS symptoms, with a larger effect size in the diet groups. Dietary interventions…
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension…
Although the past 10 years have brought a wave of novel medications and mechanisms to the management of Crohn’s disease and inflammatory bowel disease (IBD),…
Only around a third of patients with active luminal Crohn’s disease treated with an anti-TNF drug were in remission at the end of 3 years…
The gut microbiome plays an important part in a number of gastrointestinal conditions, including Clostridioides difficile infection and inflammatory bowel disease. Interest in modulating the…
Ireland will require them starting in 2026, and there are nascent efforts elsewhere to add more explicit labeling about the health risks of drinking.
